Agile Therapeutics, Inc. ( AGRX) - Stock Earnings
Stock symbol AGRX is outdated, potentially delisted? Maybe it is available on other exchange?
AGRX Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q3 | -799000 USD | 6.7 million USD |
| 2023Q4 | -4.5 million USD | 3.6 million USD |
| 2024Q1 | 1.3 million USD | 5.7 million USD |
AGRX Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2021 | -76.6 million USD | 4.1 million USD |
| 2022 | -25.4 million USD | 10.9 million USD |
| 2023 | -14.5 million USD | 19.6 million USD |
AGRX
Price: $1.51
52 week price:
Earnings Per Share: -1.70 USD
P/E Ratio: 0.21
Exchange: OQB
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Country: United States
Volume: 296349
Ebitda: -6.6 millionMarket Capitalization: 10.0 million